CN Patent

CN111989321A — Kras g12c抑制剂

Assigned to Array Biopharma Inc · Expires 2020-11-24 · 5y expired

What this patent protects

本发明涉及抑制KRas G12C的化合物。具体地说，本发明涉及不可逆地抑制KRas G12C的活性的化合物、包含所述化合物的药物组合物及其使用方法。

USPTO Abstract

本发明涉及抑制KRas G12C的化合物。具体地说，本发明涉及不可逆地抑制KRas G12C的活性的化合物、包含所述化合物的药物组合物及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN111989321A
Jurisdiction
CN
Classification
—
Expires
2020-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.